Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2016 08:30 ET | Source: VBI Vaccines Inc.

VBI Vaccines to Present Zika Vaccine Program Poster at the Keystone Symposia on Translational Vaccinology for Global Health

CAMBRIDGE, MASSACHUSETTS--(Marketwired - Oct. 27, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") is scheduled to present at the Keystone Symposia on Translational Vaccinology...
October 11, 2016 08:30 ET | Source: VBI Vaccines Inc.

VBI Vaccines Completes Pre-IND Meeting for its Glioblastoma Immunotherapy Candidate

CAMBRIDGE, MASSACHUSETTS--(Marketwired - Oct. 11, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV) (TSX:VBV) ("VBI") today announced that it has completed a pre-IND meeting with the U.S. Food and...
October 05, 2016 08:30 ET | Source: VBI Vaccines Inc.

VBI Vaccines to Present at the World Vaccine Congress Europe

CAMBRIDGE, MASSACHUSETTS--(Marketwired - Oct. 5, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") is scheduled to present at the 17th Annual World Vaccine Congress Europe on...
September 26, 2016 16:30 ET | Source: VBI Vaccines Inc.

VBI Vaccines Announces Results of Annual General and Special Meeting

CAMBRIDGE, MASSACHUSETTS--(Marketwired - Sept. 26, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") today announced the voting results from its annual general and special meeting...
September 26, 2016 08:30 ET | Source: VBI Vaccines Inc.

VBI Vaccines to Present at the Ladenburg Thalmann Healthcare Conference

CAMBRIDGE, MASSACHUSETTS--(Marketwired - Sept. 26, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") is scheduled to present at the Ladenburg Thalmann Healthcare Conference on...
September 20, 2016 08:30 ET | Source: VBI Vaccines Inc.

VBI Vaccines Completes Enrollment of Participants in the Phase I Clinical Trial of Its Preventative Cytomegalovirus Vaccine Candidate

CAMBRIDGE, MASSACHUSETTS--(Marketwired - Sept. 20, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") today announced that it has completed enrollment and initial dosing of all...
September 07, 2016 08:30 ET | Source: VBI Vaccines Inc.

VBI Vaccines to Present at the Rodman & Renshaw Annual Global Investment Conference

CAMBRIDGE, MASSACHUSETTS--(Marketwired - Sept. 7, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") is scheduled to present at the Rodman & Renshaw 18th Annual Global...
September 01, 2016 08:30 ET | Source: VBI Vaccines Inc.

VBI Vaccines to Present at the Vaccine Congress

CAMBRIDGE, MASSACHUSETTS--(Marketwired - Sept. 1, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") is scheduled to present at the 10th Vaccine Congress on Monday, September 5,...
August 29, 2016 08:30 ET | Source: VBI Vaccines Inc.

VBI Vaccines to Present at the Immuno-Oncology Summit

CAMBRIDGE, MASSACHUSETTS--(Marketwired - Aug. 29, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") is scheduled to present at the 4th Annual Immuno-Oncology Summit on Wednesday,...
August 22, 2016 08:30 ET | Source: VBI Vaccines Inc.

VBI Vaccines to Continue Enrolling Participants in the Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate Following Successful Data Safety Monitoring Board Review

CAMBRIDGE, MASSACHUSETTS--(Marketwired - Aug. 22, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV) (TSX:VBV) ("VBI") today announced that, following a review of safety data from the limited safety...